- On August 21, Hong Kong stock indices closed higher collectively, with the Hang Seng Index rising 1.21% to 26009.46 points and a total turnover of 2573 billion HKD.
- Gold and non-ferrous metal stocks surged across the board driven by rising international gold prices, while AI concept stocks rallied ahead of the Hang Seng index review.
- Insurance and software service stocks strengthened on positive financial results, whereas biomedical and new consumer stocks experienced pullbacks.
- Hong Kong stocks maintained an upward trend on August 20, with the Hang Seng Index rising 1.22% to 25807.29 points.
- The innovative drug sector surged significantly driven by Moderna mRNA vaccine developments and strong interim results, while gold stocks strengthened as spot gold broke 4500 USD.
- Meanwhile, internet technology stocks showed divergence, highlighted by Kuaishou dropping over 10% following weaker-than-expected financial results.
- At the midday close, the Hang Seng Index rose 291 points to reach 25,786, while the Hang Seng Tech Index increased by 72 points to 4,754.
- Major heavyweights such as XIAOMI, BABA, and TENCENT recorded solid gains alongside broader market movements.
- Stocks including WUXI BIO, WUXI APPTEC, BEIGENE, OOIL, and TINGYI hit new highs during the trading session.
- On August 20, Hong Kong stocks rallied collectively, with the Hang Seng Index rising 0.74% to 25684.92 points.
- Sector performance showed gold stocks surging driven by safe-haven demand, pharmaceutical stocks strengthening following positive overseas clinical trial results, and new energy vehicle stocks posting gains.
- Kuaishou shares plunged over 11% following its second-quarter financial results reporting a 36% year-on-year drop in net profit.
- Hong Kong stocks opened higher on August 20 following US market gains, with the HSI rising 284 pts or 1.11% to 25,779.
- Large-cap tech shares mostly advanced alongside strong performances in pharmaceutical, biotech, and gold mining stocks.
- Individual stock movements included BABA-W gaining nearly 2% ahead of results, KUAISHOU-W dropping over 4% due to a profit decline, and spot gold surpassing USD 4,500 per ounce.
- The 2026 market reality check demonstrates that various Hong Kong-listed companies can no longer rely on past achievements to sustain their valuations.
- Major telecom operators face traditional business declines despite expanding into computing power, while Pop Mart confronts slowing overseas sales and a lowered growth outlook.
- Meanwhile, WuXi Biologics successfully divested non-core assets to focus on antibody-drug conjugate capacity, whereas other firms struggle with legacy issues or margin pressures.